Malady Kyle insider trades
Malady Kyle has filed 181 Form 4s with the SEC that we hold, for Verizon Communications INC (VZ) (EVP and Group CEO-VZ Business) and Dexcom INC (DXCM) (Director). Across all of them we count 0 purchases worth $0 and 27 sales worth $7.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 10 sales ($525.4K). The largest single trade was a sale of 24,000 shares of Verizon Communications INC worth $979.2K, dated 2024-02-22. Of 9 sales filed since we began reading the 10b5-1 checkbox, 9 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-07-12 and the latest 2026-10-23.
Verizon Communications INC (VZ)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2023-03-13 | S, sale reported on Form 4 | 7,199 | $262.8K | 2023-03-15 | SEC |
| 2023-03-14 | S, sale reported on Form 4 | 7,546 | $277.2K | 2023-03-15 | SEC |
| 2023-03-15 | S, sale reported on Form 4 | 6,226 | $228.4K | 2023-03-17 | SEC |
| 2024-02-15 | S, sale reported on Form 4 | 15,000 | $605.0K | 2024-02-20 | SEC |
| 2024-02-22 | S, sale reported on Form 4 | 24,000 | $979.2K | 2024-02-26 | SEC |
| 2025-01-27 | S, sale reported on Form 4 | 20,000 | $810.8K | 2025-01-29 | SEC |
| 2025-01-28 | S, sale reported on Form 4 | 20,000 | $809.8K | 2025-01-30 | SEC |
| 2025-01-29 | S, sale reported on Form 4 | 11,085 | $453.2K | 2025-01-31 | SEC |
| 2025-02-03 | S, sale reported on Form 4 | 8,000 | $319.1K | 2025-02-05 | SEC |
| 2025-02-04 | S, sale reported on Form 4 | 6,590 | $261.6K | 2025-02-06 | SEC |
| 2025-04-23 | S, sale reported on Form 4 | 5,000 | $212.4K | 2025-04-24 | SEC |
| 2025-04-24 | S, sale reported on Form 4 | 10,000 | $430.2K | 2025-04-25 | SEC |
| 2025-04-30 | S, sale reported on Form 4 | 7,500 | $329.1K | 2025-05-01 | SEC |
| 2025-05-07 | S, sale reported on Form 4 | 9,000 | $396.9K | 2025-05-08 | SEC |
| 2025-05-08 | S, sale reported on Form 4 | 299 | $13.1K | 2025-05-09 | SEC |
| 2025-05-08 | S, sale reported on Form 4 | 9,701 | $425.0K | 2025-05-09 | SEC |
| 2026-08-18 | S, sale reported on Form 4 | 1,100 | $53.5K | 2026-08-19 | SEC |
| 2026-08-25 | S, sale reported on Form 4 | 1,100 | $55.1K | 2026-08-26 | SEC |
| 2026-09-01 | S, sale reported on Form 4 | 1,100 | $55.5K | 2026-09-02 | SEC |
| 2026-09-08 | S, sale reported on Form 4 | 1,100 | $55.0K | 2026-09-09 | SEC |
| 2026-09-15 | S, sale reported on Form 4 | 1,100 | $56.3K | 2026-09-16 | SEC |
| 2026-09-22 | S, sale reported on Form 4 | 1,100 | $52.4K | 2026-09-23 | SEC |
| 2026-09-29 | S, sale reported on Form 4 | 1,100 | $51.0K | 2026-09-30 | SEC |
| 2026-10-06 | S, sale reported on Form 4 | 1,100 | $50.3K | 2026-10-07 | SEC |
| 2026-10-13 | S, sale reported on Form 4 | 1,100 | $47.2K | 2026-10-14 | SEC |
| 2026-10-20 | S, sale reported on Form 4 | 1,100 | $48.9K | 2026-10-21 | SEC |
Dexcom INC (DXCM)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2025-09-05 | S, sale reported on Form 4 | 667 | $53.9K | 2025-09-09 | SEC |
Counted from the Form 4 filings this reporting owner (SEC CIK 1760581) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
